PT904056E - Processo e dispositivo para inalacao de medicamentos particulados - Google Patents

Processo e dispositivo para inalacao de medicamentos particulados

Info

Publication number
PT904056E
PT904056E PT97915445T PT97915445T PT904056E PT 904056 E PT904056 E PT 904056E PT 97915445 T PT97915445 T PT 97915445T PT 97915445 T PT97915445 T PT 97915445T PT 904056 E PT904056 E PT 904056E
Authority
PT
Portugal
Prior art keywords
inhalator
inhalation
medicament
spherical hollow
particular medicines
Prior art date
Application number
PT97915445T
Other languages
English (en)
Inventor
Michiel Van Oort
Mark J Sacchetti
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10791297&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT904056(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PT904056E publication Critical patent/PT904056E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
PT97915445T 1996-03-29 1997-03-25 Processo e dispositivo para inalacao de medicamentos particulados PT904056E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9606677.4A GB9606677D0 (en) 1996-03-29 1996-03-29 Process and device

Publications (1)

Publication Number Publication Date
PT904056E true PT904056E (pt) 2004-02-27

Family

ID=10791297

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97915445T PT904056E (pt) 1996-03-29 1997-03-25 Processo e dispositivo para inalacao de medicamentos particulados

Country Status (12)

Country Link
US (2) US20010018916A1 (pt)
EP (1) EP0904056B1 (pt)
JP (1) JP2000507862A (pt)
AT (1) ATE250922T1 (pt)
AU (1) AU724500B2 (pt)
CA (1) CA2250217A1 (pt)
DE (1) DE69725308T2 (pt)
DK (1) DK0904056T3 (pt)
ES (1) ES2208889T3 (pt)
GB (1) GB9606677D0 (pt)
PT (1) PT904056E (pt)
WO (1) WO1997036574A1 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
AU6014098A (en) * 1996-12-31 1998-07-31 Inhale Therapeutic Systems Aerosolized hydrophobic drug
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
IL135126A0 (en) * 1997-09-29 2001-05-20 Inhale Therapeutic Syst Perforated microparticles and methods of use and preparation thereof
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
MA26621A1 (fr) * 1998-04-18 2004-12-20 Glaxo Group Ltd Composition pour aerosols pharmaceutiques
GB9808802D0 (en) * 1998-04-24 1998-06-24 Glaxo Group Ltd Pharmaceutical formulations
US6660715B2 (en) 1998-11-19 2003-12-09 Massachusetts Institute Of Technology Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
FI20002215A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
US6595210B2 (en) 2000-11-27 2003-07-22 Unisia Jecs Corporation Inhalator for administering powder composition
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
DE60230502D1 (de) * 2001-05-24 2009-02-05 Alexza Pharmaceuticals Inc Verabreichung von antimigränemitteln durch inhalation
WO2002094238A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of anti-migraine compounds through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
WO2003015747A1 (en) 2001-08-13 2003-02-27 Genomed, Llc Method to treat pulmonary hypoplasia in the newborn
CA2464656C (en) 2001-11-01 2013-07-16 Nektar Therapeutics Spray drying methods and compositions thereof
CA2465779A1 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions for sustained action product delivery
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
DK2630954T3 (en) * 2002-03-20 2017-01-23 Civitas Therapeutics Inc PULMONAL SUBMISSION OF LEVODOPA
WO2003092654A1 (en) 2002-05-02 2003-11-13 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US7185647B2 (en) * 2002-08-16 2007-03-06 Schering Corporation Determination of smoothness of canisters containing inhalable medicaments
EP1581860A4 (en) * 2002-12-23 2008-05-21 Dexterra Inc MOBILE DATA AND SOFTWARE UPGRADING SYSTEM AND METHOD
US20040224674A1 (en) * 2003-04-07 2004-11-11 O'farrell Robert System and method for context sensitive mobile data and software update
AU2004228757A1 (en) * 2003-04-14 2004-10-21 Vectura Ltd Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
US8627821B2 (en) 2005-01-10 2014-01-14 Pulmatrix, Inc. Method and device for decreasing contamination
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
US20080202627A1 (en) * 2007-02-23 2008-08-28 Mas Gregory V Dosing System and Method
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
EP3090792A1 (en) * 2008-07-18 2016-11-09 Prosonix Limited Process for improving crystallinity
WO2010063286A2 (en) 2008-12-04 2010-06-10 Nordicaryan Aps A hand-held inhaler
MX354829B (es) 2009-03-26 2018-03-22 Pulmatrix Operating Co Inc Formulaciones de polvo seco y metodos para el tratamiento de enfermedades pulmonares.
US9433588B2 (en) * 2009-11-09 2016-09-06 Virginia Commonwealth Univeristy Delivery of submicrometer and nanometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery
EP2464346A1 (en) 2010-08-30 2012-06-20 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
AU2011296343B2 (en) 2010-08-30 2015-12-10 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
CN103079619B (zh) * 2010-09-06 2017-03-01 奇斯药制品公司 计量剂量吸入器和使用该计量剂量吸入器的方法
CN107096014B (zh) 2010-09-29 2022-07-15 普马特里克斯营业公司 吸入用单价金属阳离子干粉剂
DK2621488T3 (en) 2010-09-29 2019-03-04 Pulmatrix Operating Co Inc CATIONIC DRY POWDER
EP2723321A4 (en) * 2011-06-27 2015-07-01 Univ Texas RINGING PHARMACEUTICAL FORMULATIONS
CN104487075A (zh) 2012-02-29 2015-04-01 普马特里克斯公司 可吸入干粉剂
CN105324106A (zh) 2013-04-01 2016-02-10 普马特里克斯营业公司 噻托铵干粉
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3563894B1 (en) 2018-05-04 2021-12-22 Boehringer Ingelheim International GmbH Nebulizer and container
JP2021527057A (ja) * 2018-06-07 2021-10-11 キンデーバ ドラッグ デリバリー リミティド パートナーシップ フルチカゾン及びビランテロール製剤並びに吸入器

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4147766A (en) * 1976-06-09 1979-04-03 Armour Pharmaceutical Company Macrospherical particles of anti-perspirants
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
GB2146531B (en) * 1983-09-15 1987-04-29 Stc Plc Controlled release system
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4865789A (en) * 1983-11-14 1989-09-12 Akzo Nv Method for making porous structures
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
US4741872A (en) * 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
GB8713263D0 (en) * 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
JPH0762054B2 (ja) * 1987-10-13 1995-07-05 倉敷紡績株式会社 架橋重合体粒子
US4855144A (en) * 1987-10-23 1989-08-08 Advanced Polymer Systems Synthetic melanin aggregates
US4937081A (en) * 1988-01-14 1990-06-26 Daicel Chemical Industries Ltd. Process for producing porous, spherical particles
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
KR970705979A (ko) * 1994-09-29 1997-11-03 디 히스 치료용 매개체로서의 분무-건조 미소입자 (Spray-dried microparticles as therapeutic vehicles)

Also Published As

Publication number Publication date
EP0904056A1 (en) 1999-03-31
US20010018916A1 (en) 2001-09-06
ATE250922T1 (de) 2003-10-15
DK0904056T3 (da) 2004-01-19
DE69725308D1 (de) 2003-11-06
AU2292197A (en) 1997-10-22
GB9606677D0 (en) 1996-06-05
ES2208889T3 (es) 2004-06-16
AU724500B2 (en) 2000-09-21
WO1997036574A1 (en) 1997-10-09
CA2250217A1 (en) 1997-10-09
DE69725308T2 (de) 2004-08-05
EP0904056B1 (en) 2003-10-01
US20030005927A1 (en) 2003-01-09
JP2000507862A (ja) 2000-06-27

Similar Documents

Publication Publication Date Title
PT904056E (pt) Processo e dispositivo para inalacao de medicamentos particulados
PT1019022E (pt) Microparticulas perfuradas e metodos de utilizacao
US5267555A (en) Apparatus and method for ionizing medication containing mists
BR9507746A (pt) Formulação adequada para nebulização processo para preparar a fomulação recipiente uso da formulação e processo para tratar distúrbios respiratórios
AU3400501A (en) Improvements in or relating to the delivery of oral drugs
BR9510210A (pt) Dispositivo de inalação e processo para dispersão de uma substância farmaceuticamente ativa em uma câmara de dispersão e para administração de uma dose de uma substância farmaceuticamente ativa em pó
GEP20043258B (en) Systems and Methods for Aerosolizing Pharmaceutical Formulations
EE03221B1 (et) Inhaleeritavad ravimpreparaadid, nende valmistamise protsess ja inhalaator nende kasutamiseks
GB9806462D0 (en) Improved compositions for inhalation
BR0006237A (pt) Inalador em aerossol, e, processo de tratamentode um sujeito com um agente farmacêutico
SE9402383L (sv) Förfarande och anordning för att införa en aktiv substans till en persons andningssystem
IT9041667A0 (it) Inalatore per aerosolterapia basato sul sistema "usa e getta" dei due componenti "mascherina per inalazione" e "contenitore portafarmaco".